Editorial · 29 Nov 2024
Research articlePublished 16 Dec 2019
Cardiogenic shock
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: The cardiogenic shock is a state of endorgan dysfunction, secondary to insufficient cardiac output despite adequate preload, as a result of left ventricular, right ventricular or biventricular dysfunction. Cardiogenic shock occurs in up to 10% of patients presenting with acute myocardial infarction and is the leading cause of death. Objective: To conduct a review of cardiogenic shock. Methodology: The search was performed in the databases PUBMED/MEDLINE, EMBASE and Google Scholar with the search terms: Cardiogenic shock and Epidemiology or Pathophysiology or Diagnosis or Treatment. We selected the most relevant studies on cardiogenic shock. Results: We provided a general description of the definition, epidemiology, clinical manifestations, causes, pathophysiology and treatment of cardiogenic shock. The clinical syndrome of cardiogenic shock has been described as: a systolic blood pressure of less than 90 mm Hg, or greater than 30 mm Hg below baseline BP, for at least 30 minutes, with signs of a reduced cardiac output. The most common cause of cardiogenic shock is acute coronary syndrome, accounting for about 70% to 80% of cardiogenic shock cases. The basic treatment measures include initial stabilization with volume expansion to obtain euvolaemia, vasopressors, and inotropes plus additional therapy for the prevention or treatment of multiorgan system dysfunction. Norepinephrine is associated with fewer arrhythmias and may be the vasopressor of choice in many patients with cardiogenic shock. Coronary reperfusion is the main evidence-based therapeutic intervention for patients with acute MI presenting with cardiogenic shock. Traditionally, intra-aortic balloon pumps have been the main support system, there has been interest in improved mechanical support devices because these may make revascularization safer.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Sep 2024
The Role of Dobutamine in Heart Failure and Cardiogenic Shock: Benefits, Risks and Future Directions
Article · 29 Apr 2024
Current management of cardiogenic shock from stress-induced cardiomyopathy: Consideration of catecholamine excess and left ventricular outflow tract obstruction
Article · 28 Feb 2024
Comprehensive Management of Cardiogenic Shock: Strategies, Challenges, and Advances
Article · 27 Nov 2023
Comprehensive Management of Cardiogenic Shock: A Critical Endeavor
More from this journal
The newest in Interventional Cardiology.
Article · 27 May 2026
Commentary on Stent-Induced Coronary Stenosis in a Previously Noncritical Segment Following PCI: A Case Report
Article · 24 Mar 2026
Redo arteriovenous fistula in end stage kidney disease: Risk factors and outcomes in Taiz – Yemen
Article · 23 Feb 2026
The Silent Giant : Incidental Discovery of a Large Left Atrial Myxoma
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInterventional Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Maria Monica Lopez Rodriguez”
- BylineArticles whose byline prints “Carlos Javier Vizcaino Guerrero”
- BylineArticles whose byline prints “Juan Camilo Arcia Garzon”
- BylineArticles whose byline prints “Andres Felipe Segura Avila”
- BylineArticles whose byline prints “Juan David Vega Padilla”
